Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 191-200 of 411 for multiple

Edit search filters
  1. Dinaciclib, Bortezomib, And Dexamethasone In Treating Patients With Relapsed Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Study Evaluating ABT-199 In Subjects With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study To Evaluate The Safety, Pharmacokinetics, And Efficacy Of Isatuximab In Patients With Multiple Myeloma

    Scottsdale/Phoenix, AZ

  4. Panobinostat And Everolimus In Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, Or Hodgkin Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Lenalidomide And Dexamethasone With Or Without Anakinra In Treating Patients With Early Stage Multiple Myeloma

    Rochester, MN

  6. Pembrolizumab, Lenalidomide, And Dexamethasone In Treating Patients With Newly Diagnosed Multiple Myeloma Eligible For Stem Cell Transplant

    Jacksonville, FL, Rochester, MN

  7. A Study To Evaluate Daratumumab In Treating Transplant-Eligible Participants With Multiple Myeloma

    Jacksonville, FL

  8. A Study To Evaluate ION251 To Treat Patients With Relapsed/Refractory Multiple Myleoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Long-term Safety And Efficacy Of Multiple Long-acting Antibodies Alone And In Combinations For IBD

    Rochester, MN

  10. A Phase 1 Study Evaluating CPI-0610 In Patients With Previously Treated Multiple Myeloma

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer